Genome Engineering Paves the Way for Sickle Cell Cure

Newswise imageA team of physicians and laboratory scientists has taken a key step toward a cure for sickle cell disease, using CRISPR-Cas9 gene editing to fix the mutated gene responsible for the disease in stem cells from the blood of affected patients. For the first time, they have corrected the mutation in a proportion of stem cells that is high enough to produce a substantial benefit in sickle cell patients.

Source link

Related posts

First biomarker evidence of DDT-autism link


Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies


Americans' Diet Improving … Slowly


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World